Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04121741
Other study ID # 35864
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 17, 2020
Est. completion date January 30, 2024

Study information

Verified date March 2023
Source Medical College of Wisconsin
Contact Amberly A Anger
Phone 414-805-3148
Email AANGER@MCW.EDU
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cardiovascular disease (CVD) claims more lives each year than cancer and chronic respiratory disease combined. Participation in cardiac rehabilitation (CR) reduces mortality and risk of a major cardiovascular event in secondary prevention populations, including older adults. Older adults are less likely to participate in CR, as comorbidities in this population, including arthritis and chronic obstructive pulmonary disease, make participation difficult. Singing is a physical activity that involves components of the vagal nerves manifested as changes in cardiac autonomic regulation. Unlike physical exercise, the effects of singing on cardiovascular health has not been well-studied. The hypothesis for this project is that older patients with CVD will have favorable improvement in cardiovascular biomarkers, including, endothelial function and heart rate variability (HRV), after 30 minutes of singing.


Description:

This proposal seeks to create, optimize and test two different singing interventions in older patients with CVD. The study will consist of three arms, according to a randomized, single-blind, crossover, sham procedure-controlled design. Sixty-five total participants will each have three visits on three different occasions for the following interventions: 1. a 30-minute period of guided singing from an in-person music therapist 2. a 30-minute period of singing along to an instructional video including a professor of voice and "inexperienced, older singing student" 3. a 30-minute sham intervention (subjects will undergo a hearing test) The goal will be to determine which singing intervention, if any, is superior to the other - as this would be important to guide longer and larger clinical trials in the field. Knowledge gained from this proposal will improve understanding of biologic mechanisms of singing behaviors, as it relates to CVD.


Recruitment information / eligibility

Status Recruiting
Enrollment 65
Est. completion date January 30, 2024
Est. primary completion date July 30, 2023
Accepts healthy volunteers No
Gender All
Age group 55 Years to 79 Years
Eligibility Inclusion Criteria: - English Speaking - Have a history of coronary artery disease (defined as history of myocardial infarction, coronary stenosis >50%, percutaneous coronary intervention with stent placement, balloon angioplasty, or coronary arterial bypass grafting) Exclusion Criteria: - Subjects with a permanent pacemaker or implantable cardioverter defibrillator (ICD) implanted - Patients with a history of atrial fibrillation, flutter or atrial tachycardia - Parkinson's disease or a tremor - Amputated upper extremity or presence of upper-arm (dialysis) fistula - Fingernail onychomycosis (fungal infections resulting in thickening of the nails) - Pregnancy - Current illicit drug use (marijuana, tobacco, cocaine, amphetamines, etc.) - Current excessive alcohol use (defined as more than 14 drinks/week for women, more than 28 drinks/week for men) - Unstable coronary heart disease (active symptoms of chest discomfort) - History of a Stroke or TIA or peripheral arterial disease - Known history of cognitive impairment or inability to follow study procedures - Cancer requiring systemic treatment within five years of enrollment. - Subjects requiring supplemental oxygen use - Non-English speaking subjects (video with lyrics are taped in English)

Study Design


Intervention

Other:
Singing with Music Therapist
Music therapy sessions will begin with vocal and breathing warm-up exercises for about 10 minutes. The Music Therapist will play the songs (chosen from a list by the subject) to sing along to and will alter the characteristics of the music (volume, tempo, level of support) to ensure a successful experience for subjects and motivate them to put forth more effort into singing the song. The music therapist will continue to coach throughout the 30-minute session, reminding subjects of strategies practiced and how to implement those strategies while singing. Music therapy sessions will be led by Erica Flores, MT-BC, WMTR, Owner of Healing Harmonies Music Therapy, or a member of her team. Erica and her team of MTs were trained in Neurological Music Therapy.
Singing with Guided Video
The videos will include a vocal warm-up (10 minutes long). The subject will then have the option to select and sing two songs (10 minutes each), with offerings in four music genres including Folk, Pop, Country, and a Hymn. Each piece will vary in tempo, melodic contour, and rhythm. The total duration of singing via this format will be 30 minutes.
Control Arm
30 minute rest period, no singing will take place during this arm. During this rest period a member of the study team will assist the subject in a hearing test using headphones, a tablet, and a trumpet app. This is done to asses the current hearing level of the subject.

Locations

Country Name City State
United States Medical College of Wisconsin Milwaukee Wisconsin

Sponsors (1)

Lead Sponsor Collaborator
Medical College of Wisconsin

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other the change in TNF-alpha, IL-1 Beta, IL-6, and IL-8 measure the change in TNF-alpha, IL-1 Beta, IL-6, and IL-8 at baseline and 30 minutes later (after interventions or sham)
Other Visual Mood Score Arts Observation Scale to evaluate the effect of performing arts activities in healthcare settings. Two reactions (relaxation and distraction) will be scored by the research coordinator nurse based on direct observation of the subjects during the singing intervention. The qualitative portion of this instrument enables the collection of personal feedback and quotations from subjects. Observers (research team) can also gather more detailed accounts of subjects' responses to activities, including experience and perceptions at baseline and 30 minutes later (after interventions or sham)
Primary change in vascular (endothelial) function Measure endothelial function and brachial artery flow-mediated dilation At baseline and after 30-minute singing and sham intervention(s)
Primary change in vascular (endothelial) function Measure endothelial function (reactive hyperemia index, and PAT ratio) through finger plethysmography using EndoPAT At baseline and after 30-minute singing and sham intervention(s)
Secondary level of exertion achieved during singing BORG Rating of Perceived Exertion after 30-minute singing (and sham) interventions
Secondary level of exertion achieved during singing percent of maximum predicted heart rate achieved after 30-minute singing (and sham) interventions
Secondary cardiac hemodynamics heart rate variability will be measured before, during and post singing at baseline and after 30-minute singing and sham intervention(s)
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04098172 - Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR N/A